Clinical Study on the Consistency of 15-valent Pneumococcal Conjugate Vaccine in Three Batches of 3-month-old Population and the Immunogenicity and Safety of Vaccination in 7-5-year-old Population
Latest Information Update: 17 Jul 2023
At a glance
- Drugs Pneumococcal conjugate vaccine 15-valent-Beijing Zhifei Lvzhu Biopharmaceutical (Primary) ; Pneumococcal 13-valent CRM197 vaccine conjugate
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- Sponsors Beijing Zhifei Lvzhu Biopharmaceutical
Most Recent Events
- 17 Jul 2023 New trial record